A Multicenter, Observational, Longitudinal Study To Evaluate The Efficacy and Safety of Combination of Sofosbuvir and Daclatasvir In Patients With Chronic Hepatitis C.

Trial Profile

A Multicenter, Observational, Longitudinal Study To Evaluate The Efficacy and Safety of Combination of Sofosbuvir and Daclatasvir In Patients With Chronic Hepatitis C.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2015

At a glance

  • Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms APROVVIE 2
  • Most Recent Events

    • 10 Aug 2015 New trial record
    • 26 Apr 2015 Interim results presented at the 50th Annual Meeting of the European Association for the Study of the Liver (n = 140).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top